Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammatory Targets in Diabetic Nephropathy
Javier Donate‐Correa, Desirée Luis-Rodríguez, Ernesto Martín‐Núñez, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 2, pp. 458-458
Open Access | Times Cited: 180

Showing 1-25 of 180 citing articles:

Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment
Nur Samsu
BioMed Research International (2021) Vol. 2021, pp. 1-17
Open Access | Times Cited: 608
Immune responses in diabetic nephropathy: Pathogenic mechanisms and therapeutic target
Jiahao Chen, Qinhui Liu, Jinhan He, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 96
Pathophysiology of mesangial expansion in diabetic nephropathy: mesangial structure, glomerular biomechanics, and biochemical signaling and regulation
Haryana Y. Thomas, Ashlee N. Ford Versypt
Journal of Biological Engineering (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 81
Quercetin: an effective polyphenol in alleviating diabetes and diabetic complications
Lei Yan, Mostafa Vaghari‐Tabari, Faezeh Malakoti, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 28, pp. 9163-9186
Closed Access | Times Cited: 78
Therapeutic Efficacy of Hydroalcoholic Extract of Euphorbia prostrata Aiton in NAD-STZ-Induced Diabetic Nephropathy: A Multifaceted Intervention Targeting Oxidative Stress and Inflammation
Nikhil Garg, Ashi Mannan, Maneesh Mohan, et al.
Obesity Medicine (2025), pp. 100579-100579
Closed Access | Times Cited: 4
Renoprotective mechanisms of celastrol in high glucose-mediated HK-2 cell injury through inhibition of the PI3K/Akt/NF-κB signalling pathway
Xiaojuan Wang, Mohamad Hafizi Abu Bakar, Mohd Asyraf Kassim, et al.
Biochemistry and Biophysics Reports (2025) Vol. 41, pp. 101928-101928
Closed Access | Times Cited: 2
Special Issue “Diabetic Nephropathy: Diagnosis, Prevention and Treatment”
Marta Ruíz-Ortega, Raúl R. Rodrigues-Díez, Carolina Lavoz, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 3, pp. 813-813
Open Access | Times Cited: 106
IGFBP5 promotes diabetic kidney disease progression by enhancing PFKFB3-mediated endothelial glycolysis
Chengcheng Song, Shuqiang Wang, Zhangning Fu, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 49
TLR9 regulates NLRP3 inflammasome activation via the NF-kB signaling pathway in diabetic nephropathy
Jin-feng Shen, Zaiyou Dai, Yunsheng Li, et al.
Diabetology & Metabolic Syndrome (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 41
How Curcumin Targets Inflammatory Mediators in Diabetes: Therapeutic Insights and Possible Solutions
Yaseen Hussain, Haroon Khan, Ghallab Alotaibi, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4058-4058
Open Access | Times Cited: 41
The Role of Oxidative Stress-Mediated Inflammation in the Development of T2DM-Induced Diabetic Nephropathy: Possible Preventive Action of Tannins and Other Oligomeric Polyphenols
Gohar Sahakyan, Anne Véjux, Naira Sahakyan
Molecules (2022) Vol. 27, Iss. 24, pp. 9035-9035
Open Access | Times Cited: 40
Autophagy and its therapeutic potential in diabetic nephropathy
Yu-Peng Han, Lijuan Liu, Jia-Lin Yan, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 28
PS-MPs promotes the progression of inflammation and fibrosis in diabetic nephropathy through NLRP3/Caspase-1 and TGF-β1/Smad2/3 signaling pathways
Lixiang Feng, Chen Chen, Xi Xiong, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 273, pp. 116102-116102
Open Access | Times Cited: 8
Protective effect of orientin on diabetic nephropathy in rat models of high-fat diet and streptozotocin-induced diabetes
Raad Saad Luty, Adeeb Ahmed Kadhim Al-Zubaidy, Arif Sami Malik, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access | Times Cited: 1
Urinary Exosomal MiRNA-4534 as a Novel Diagnostic Biomarker for Diabetic Kidney Disease
Yanyan Zhao, Ao Shen, Feng Guo, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 54
Targeting inflammation for the treatment of Diabetic Kidney Disease: a five-compartment mechanistic model
Alexis Hofherr, Julie Williams, Li‐Ming Gan, et al.
BMC Nephrology (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 32
Astragaloside IV Attenuates High-Glucose-Induced Impairment in Diabetic Nephropathy by Increasing Klotho Expression via the NF-κB/NLRP3 Axis
Jiaxin He, Jialin Cui, Yimin Shi, et al.
Journal of Diabetes Research (2023) Vol. 2023, pp. 1-22
Open Access | Times Cited: 17
Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Increases Antioxidative Capacity and Improves Renal Function in Diabetic Rats
Habib Yaribeygi, Mohammad Amin Hemmati, Fatemeh Sokouti Nasimi, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 11, pp. 3815-3815
Open Access | Times Cited: 17
Diabetic nephropathy: A twisted thread to unravel
Neha Dagar, Pamelika Das, Priya Bisht, et al.
Life Sciences (2021) Vol. 278, pp. 119635-119635
Closed Access | Times Cited: 39
Wnt5a promotes renal tubular inflammation in diabetic nephropathy by binding to CD146 through noncanonical Wnt signaling
Xiaomei Li, Jiejun Wen, Yang Dong, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 33
Sitagliptin Mitigates Diabetic Nephropathy in a Rat Model of Streptozotocin-Induced Type 2 Diabetes: Possible Role of PTP1B/JAK-STAT Pathway
Sarah M. AL-Qabbaa, Samaher I. Qaboli, Tahani K. Alshammari, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6532-6532
Open Access | Times Cited: 14
Advances in understanding and treating diabetic kidney disease: focus on tubulointerstitial inflammation mechanisms
Chengren Xu, Xiaowen Ha, Shufen Yang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 14
Characterization of diabetic kidney disease in 235 patients: clinical and pathological insights with or without concurrent non-diabetic kidney disease
Mengjie Jiang, Hongyu Chen, Jing Luo, et al.
BMC Nephrology (2025) Vol. 26, Iss. 1
Open Access
Mefunidone ameliorates diabetic kidney disease in STZ and db/db mice
Yupeng Jiang, Feifei Xie, Xin Lv, et al.
The FASEB Journal (2020) Vol. 35, Iss. 1
Closed Access | Times Cited: 38
Nephroprotective effect of Vanillic acid in STZ-induced diabetic rats
Savita Kumari, Anjoo Kamboj, Manish Wanjari, et al.
Journal of Diabetes & Metabolic Disorders (2021) Vol. 20, Iss. 1, pp. 571-582
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top